N-[(1S)-3-[4-[(2S,3R)-4-(4,7-diazaspiro[2.5]octan-7-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;N-[(1S)-3-[4-[(2S,3R)-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[3-(2-hydroxypropan-2-yl)azetidin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide

C136H193F4N23O22 — CID 167585651

About N-[(1S)-3-[4-[(2S,3R)-4-(4,7-diazaspiro[2.5]octan-7-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;N-[(1S)-3-[4-[(2S,3R)-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[3-(2-hydroxypropan-2-yl)azetidin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide

N-[(1S)-3-[4-[(2S,3R)-4-(4,7-diazaspiro[2.5]octan-7-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;N-[(1S)-3-[4-[(2S,3R)-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[3-(2-hydroxypropan-2-yl)azetidin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide (PubChem CID 167585651) has the molecular formula C136H193F4N23O22 and a molecular weight of 2578.17 g/mol. Its IUPAC name is N-[(1S)-3-[4-[(2S,3R)-4-(4,7-diazaspiro[2.5]octan-7-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;N-[(1S)-3-[4-[(2S,3R)-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[3-(2-hydroxypropan-2-yl)azetidin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide.

Molecular Properties

• Compound Name: N-[(1S)-3-[4-[(2S,3R)-4-(4,7-diazaspiro[2.5]octan-7-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;N-[(1S)-3-[4-[(2S,3R)-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[3-(2-hydroxypropan-2-yl)azetidin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide
• PubChem CID: 167585651
• Molecular Formula: C136H193F4N23O22
• Molecular Weight: 2578.17 g/mol
• Exact Mass: 2576.46
• IUPAC Name: N-[(1S)-3-[4-[(2S,3R)-4-(4,7-diazaspiro[2.5]octan-7-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;N-[(1S)-3-[4-[(2S,3R)-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[3-(2-hydroxypropan-2-yl)azetidin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide
• SMILES: CCC(=O)N[C@@H](C(=O)N1CC(C(C)(C)O)C1)[C@@H](C)c1ccc(CC(=O)[C@@H](NC(=O)c2nonc2CC)C2CCC(C)CC2)c(F)c1.CCC(=O)N[C@@H](C(=O)N1CCN(CCO)CC1)[C@@H](C)c1ccc(CC(=O)[C@@H](NC(=O)c2nonc2CC)C2CCC(C)CC2)c(F)c1.CCC(=O)N[C@@H](C(=O)N1CCNC2(CC2)C1)[C@@H](C)c1ccc(CC(=O)[C@@H](NC(=O)c2nonc2CC)C2CCC(C)CC2)c(F)c1.CCC(=O)N[C@@H](C(=O)N1C[C@@H](C)N[C@@H](C)C1)[C@@H](C)c1ccc(CC(=O)[C@@H](NC(=O)c2nonc2CC)C2CCC(C)CC2)c(F)c1
• InChI: InChI=1S/C34H49FN6O6.C34H47FN6O5.C34H49FN6O5.C34H48FN5O6/c1-5-27-32(39-47-38-27)33(45)37-31(23-9-7-21(3)8-10-23)28(43)20-25-12-11-24(19-26(25)35)22(4)30(36-29(44)6-2)34(46)41-15-13-40(14-16-41)17-18-42;1-5-26-31(40-46-39-26)32(44)38-30(22-9-7-20(3)8-10-22)27(42)18-24-12-11-23(17-25(24)35)21(4)29(37-28(43)6-2)33(45)41-16-15-36-34(19-41)13-14-34;1-7-27-32(40-46-39-27)33(44)38-31(23-11-9-19(3)10-12-23)28(42)16-25-14-13-24(15-26(25)35)22(6)30(37-29(43)8-2)34(45)41-17-20(4)36-21(5)18-41;1-7-26-31(39-46-38-26)32(43)37-30(21-11-9-19(3)10-12-21)27(41)16-23-14-13-22(15-25(23)35)20(4)29(36-28(42)8-2)33(44)40-17-24(18-40)34(5,6)45/h11-12,19,21-23,30-31,42H,5-10,13-18,20H2,1-4H3,(H,36,44)(H,37,45);11-12,17,20-22,29-30,36H,5-10,13-16,18-19H2,1-4H3,(H,37,43)(H,38,44);13-15,19-23,30-31,36H,7-12,16-18H2,1-6H3,(H,37,43)(H,38,44);13-15,19-21,24,29-30,45H,7-12,16-18H2,1-6H3,(H,36,42)(H,37,43)/t21?,22-,23?,30+,31-;20?,21-,22?,29+,30-;19?,20-,21+,22-,23?,30+,31-;19?,20-,21?,29+,30-/m0000/s1
• InChIKey: HTOUIEXRPCMVPR-NPLYSYHLSA-N
• XLogP: 13.56
• TPSA: 605.76 Ų
• H-Bond Donors: 12
• H-Bond Acceptors: 33
• Rotatable Bonds: 51
• Heavy Atoms: 185
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2578.17
LogP ≤ 5	13.56
H-Bond Donors ≤ 5	12
H-Bond Acceptors ≤ 10	33

Frequently Asked Questions

What is the IUPAC name of N-[(1S)-3-[4-[(2S,3R)-4-(4,7-diazaspiro[2.5]octan-7-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;N-[(1S)-3-[4-[(2S,3R)-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[3-(2-hydroxypropan-2-yl)azetidin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide?

The IUPAC name of N-[(1S)-3-[4-[(2S,3R)-4-(4,7-diazaspiro[2.5]octan-7-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;N-[(1S)-3-[4-[(2S,3R)-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[3-(2-hydroxypropan-2-yl)azetidin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide (CID 167585651) is N-[(1S)-3-[4-[(2S,3R)-4-(4,7-diazaspiro[2.5]octan-7-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;N-[(1S)-3-[4-[(2S,3R)-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[3-(2-hydroxypropan-2-yl)azetidin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide.

What is the SMILES notation for N-[(1S)-3-[4-[(2S,3R)-4-(4,7-diazaspiro[2.5]octan-7-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;N-[(1S)-3-[4-[(2S,3R)-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[3-(2-hydroxypropan-2-yl)azetidin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide?

The canonical SMILES for N-[(1S)-3-[4-[(2S,3R)-4-(4,7-diazaspiro[2.5]octan-7-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;N-[(1S)-3-[4-[(2S,3R)-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[3-(2-hydroxypropan-2-yl)azetidin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide is CCC(=O)N[C@@H](C(=O)N1CC(C(C)(C)O)C1)[C@@H](C)c1ccc(CC(=O)[C@@H](NC(=O)c2nonc2CC)C2CCC(C)CC2)c(F)c1.CCC(=O)N[C@@H](C(=O)N1CCN(CCO)CC1)[C@@H](C)c1ccc(CC(=O)[C@@H](NC(=O)c2nonc2CC)C2CCC(C)CC2)c(F)c1.CCC(=O)N[C@@H](C(=O)N1CCNC2(CC2)C1)[C@@H](C)c1ccc(CC(=O)[C@@H](NC(=O)c2nonc2CC)C2CCC(C)CC2)c(F)c1.CCC(=O)N[C@@H](C(=O)N1C[C@@H](C)N[C@@H](C)C1)[C@@H](C)c1ccc(CC(=O)[C@@H](NC(=O)c2nonc2CC)C2CCC(C)CC2)c(F)c1.

What is the InChIKey of N-[(1S)-3-[4-[(2S,3R)-4-(4,7-diazaspiro[2.5]octan-7-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;N-[(1S)-3-[4-[(2S,3R)-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[3-(2-hydroxypropan-2-yl)azetidin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide?

The InChIKey is HTOUIEXRPCMVPR-NPLYSYHLSA-N. The full InChI is InChI=1S/C34H49FN6O6.C34H47FN6O5.C34H49FN6O5.C34H48FN5O6/c1-5-27-32(39-47-38-27)33(45)37-31(23-9-7-21(3)8-10-23)28(43)20-25-12-11-24(19-26(25)35)22(4)30(36-29(44)6-2)34(46)41-15-13-40(14-16-41)17-18-42;1-5-26-31(40-46-39-26)32(44)38-30(22-9-7-20(3)8-10-22)27(42)18-24-12-11-23(17-25(24)35)21(4)29(37-28(43)6-2)33(45)41-16-15-36-34(19-41)13-14-34;1-7-27-32(40-46-39-27)33(44)38-31(23-11-9-19(3)10-12-23)28(42)16-25-14-13-24(15-26(25)35)22(6)30(37-29(43)8-2)34(45)41-17-20(4)36-21(5)18-41;1-7-26-31(39-46-38-26)32(43)37-30(21-11-9-19(3)10-12-21)27(41)16-23-14-13-22(15-25(23)35)20(4)29(36-28(42)8-2)33(44)40-17-24(18-40)34(5,6)45/h11-12,19,21-23,30-31,42H,5-10,13-18,20H2,1-4H3,(H,36,44)(H,37,45);11-12,17,20-22,29-30,36H,5-10,13-16,18-19H2,1-4H3,(H,37,43)(H,38,44);13-15,19-23,30-31,36H,7-12,16-18H2,1-6H3,(H,37,43)(H,38,44);13-15,19-21,24,29-30,45H,7-12,16-18H2,1-6H3,(H,36,42)(H,37,43)/t21?,22-,23?,30+,31-;20?,21-,22?,29+,30-;19?,20-,21+,22-,23?,30+,31-;19?,20-,21?,29+,30-/m0000/s1.

What are the key properties of N-[(1S)-3-[4-[(2S,3R)-4-(4,7-diazaspiro[2.5]octan-7-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;N-[(1S)-3-[4-[(2S,3R)-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[3-(2-hydroxypropan-2-yl)azetidin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide?

N-[(1S)-3-[4-[(2S,3R)-4-(4,7-diazaspiro[2.5]octan-7-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;N-[(1S)-3-[4-[(2S,3R)-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[3-(2-hydroxypropan-2-yl)azetidin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide has a molecular weight of 2578.17 g/mol, XLogP of 13.56, 51 rotatable bonds, 12 hydrogen bond donors, and 33 hydrogen bond acceptors.

Where does this data come from?

All data for N-[(1S)-3-[4-[(2S,3R)-4-(4,7-diazaspiro[2.5]octan-7-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;N-[(1S)-3-[4-[(2S,3R)-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-[3-(2-hydroxypropan-2-yl)azetidin-1-yl]-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide is sourced from PubChem (CID 167585651), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).